Search
Facebook Twitter RSS
 
 

 

Print

 

Submit a question
to the Forum

 

2002 Discussions (listed in reverse chronological order)

Please click HERE to access archived discussions by year posted, and HERE to access archived discussions by topic. You may also use the search tool located in the navigation bar.

Submit a question to the Forum?

Subscribe to the e-Network Forum Newsletter

Date Posted Subject
Dec. 31, 2002 Do FDA recommendations regarding deferral of donations by recent recipients of smallpox vaccine apply to persons wishing to make an autologous donation? ADDENDA Jan. 3 & 6, 2003
Dec. 30, 2002 Improving the process of patient identification - 2003 update ADDENDA Jan. 8, 2006
Dec. 30, 2002 Antibody identification using ficin-treated red cells and a PEG enhancement medium ADDENDA Jan. 3 & 10, 2003
Dec. 29, 2002 Policies for managing donors and blood products in countries endemic for malaria ADDENDA Dec. 30
Dec. 12, 2002 How do hospital Transfusion Services validate the integrity of blood products transported in a Pneumatic Tube System?
Dec. 12, 2002 How do Transfusion Services investigate blood components suspected of causing bacterial sepsis in recipients?
Dec. 10, 2002 Should automatic external defibrillators (AED) be available in the donor collection setting (esp. at mobile sites)? ADDENDA Dec. 12, 13, 17 & 18; June 29 & 30; July 1, 2003
Dec. 5, 2002 Should pre-transfusion ABO/Rh testing be performed twice, and if so, on different samples or by different personnel? ADDENDA Dec. 6, 9, 10, 12 & 20; Jan. 8 & 9, 2003; July 20, 26, 28, Aug. 3, 10, 15, 24 & 26, 2004; Dec 28 & 31, 2004; Jan 24, May 3, 4, 8, 10, 11 & 14, 2005; Sept. 21 & 29, 2006
Dec. 4, 2002 2,3-DPG kits and reagents needed for red cell storage studies ADDENDA Dec. 11, 2002; Jan. 9, 17, 21 & 27; Feb. 5 & May 6, 2003; Apr. 8, 2006; Nov. 13, 2007
Dec. 1, 2002 What are best practices for building a frozen serum repository of blood donor samples for possible future infectious agent testing? ADDENDA Dec. 2, 3, 8 & 9
Nov. 26, 2002 Emergency release and who can sign for untested or uncrossmatched blood ADDENDA Nov. 27 & Dec. 5 & 13
Nov. 23, 2002 Alternatives to bleach for disinfecting equipment and countertops ADDENDA Dec. 8
Nov. 21, 2002 How do colleagues test for and report Rh typing results of individuals who are weak D positive? ADDENDA Jan. 18, 2009
Nov. 16, 2002 When the supernatant of a red cell unit shows visible discoloration suggesting hemolysis, should it be issued for transfusion? ADDENDA Nov. 20, 2002; Oct 28, 2004; May 30, 2007; Mar. 4, 2008
Nov. 13, 2002 Is it acceptable practice to administer multiple blood products simultaneously to a patient? ADDENDA Nov. 14 & 20
Nov. 13, 2002 Ensuring proper blood storage and patient identification in ambulatory surgery centers lacking onsite laboratory support ADDENDA Dec. 11
Nov. 12, 2002 Prestorage leukoreduction for prevention of transfusion-transmitted CMV infection - current AABB recommendations
Nov. 9, 2002 Experience with benchmarking data to improve local practices in transfusion medicine
Nov. 8, 2002 A case report of the mysterious development of anti-D in pregnancy ADDENDA Nov. 12 & 13; Mar. 25 & 27, 2003
Nov. 8, 2002 Red cells for neonates on ECMO - Questions about the study by Eder et al. suggesting that additive RBC are as safe as CPD/A RBC  
Nov. 7, 2002 Reimbursement for the computer crossmatch procedure - re-revisited (from Aug. 29, 2002)
Nov. 6, 2002 What is the risk that a blood donation might cause transmission of Lyme Disease? ADDENDA Nov. 10, 2002; Aug. 13, 2003
Nov. 5, 2002 Status of automated red cell exchanges (ARBCx) as a treatment modality in sickle cell disease ADDENDA Nov. 7 & 8
Nov. 4, 2002 Platelet transfusions during cardiothoracic surgery ADDENDA Nov. 26 & Dec. 6
Nov. 2, 2002 Management of thrombocytopenia associated with therapeutic plasma exchange (TPE), when the thrombocytopenia is believed to be heparin-induced ADDENDA Nov. 4 & 5
Oct. 31, 2002 Should sickle cell trait individuals be eligible to make plateletpheresis donations
Oct. 29, 2002 Are concerns about recent aspirin ingestion by whole blood donors justified? ADDENDA Oct. 30 & 31
Oct. 27, 2002 Should RBCs used for intrauterine transfusion be washed and/or adjusted to a high Hct? ADDENDA Oct. 28 & 30
Oct. 24, 2002 What are the upper and lower hemoglobin/hematocrit levels used by blood collection centers to decide when to refer a donor for further medical evaluation?
Oct. 22, 2002 Does the Joint Commission for Accreditation of Healthcare Organizations (JCAHO) require hospitals to have a Transfusion Committee? ADDENDA Jan. 8, 2006
Oct. 22, 2002 Should a test for fetomaternal hemorrhage (FMH) be done before administering Rh Immune Globulin to Rh-negative women at risk of FMH in early pregnancy? ADDENDA Oct. 23; Oct. 7, 26 & 28, 2005
Oct. 11, 2002 Unexpected red cell alloantibodies detected in SERUM but not in PLASMA ADDENDA Oct. 14
Oct. 9, 2002 Transfusion practices during and after reinfusion of blood salvaged during surgery 
Oct. 8, 2002 Methods used to screen blood donors for anemia ADDENDA Oct. 19; UPDATE Nov. 19
Oct. 1, 2002 Donor deferral following widespread smallpox vaccination ADDENDA Oct. 2 & 3, Nov. 26; Jan 31, 2005
Sept. 30, 2002 What are the personnel requirements for hanging blood components and signing off on the transfusion records? ADDENDA Nov. 7, 2007
Sept. 25, 2002 Should we worry about cold-reacting antibodies in patients undergoing hypothermia for cardiac surgery? (REVISITED) ADDENDA Nov. 21 & 26, Dec. 15; May 22, June 2 & Sept. 22, 2003; Sept 30, 2004; May 26, 2005; Jan. 12 & 18, 2009
Sept. 24, 2002 Improving the process of patient identification and specimen tube labeling ADDENDA Sept. 25 & 26
Sept. 19, 2002 Reconciling concerns about volume overload in sensitive neonates with the regulatory requirement to complete blood infusions within 4 hours ADDENDA Sept. 20 & 26
Sept. 18, 2002 Using automatic IV infusion pumps for the transfusion of red cells ADDENDA Sept. 19 & 22; Jan. 28, 2009
Sept. 13, 2002 Is Rh Immunoglobulin (RhIG) necessary when platelets from Rh-incompatible donors are given to females of child-bearing potential?
Sept. 12, 2002 Monitoring temperature of blood products transported within the hospital ADDENDA Sept. 14, 16 & 18; May 12, 22 & 24, 2006; Feb. 5 & 15, 2007
Sept. 11, 2002 Is an attending physician's countersignature required for transfusion consent forms? ADDENDA Sept. 12 & 18; Jan. 29, 2008
Sept. 9, 2002 Overriding a patient's request to refuse transfusion ADDENDA Sept. 10, 16 & 17
Sept. 7, 2002 Is Interleukin-11 of value in raising the platelet count in surgical patients (Jehovah's Witnesses) with thrombocytopenia? ADDENDA Sept. 11 & Nov. 15
Sept. 5, 2002 Should perfusionists in the operating room be allowed to administer units of blood? ADDENDA Sept. 9
Sept. 4, 2002 Alternatives to commercial ficin for treating red cells for allogeneic adsorption ADDENDA Sept. 6
Aug. 29, 2002 Problem with California State Donor Deferral File of Aug 1, 2002
Aug. 29, 2002 Transfusion medicine leaders urge blood collection community to immediately initiate program to detect bacteria in platelet products ADDENDA Aug. 30, Sept. 4, 6, 11, 13 & 16; Mar. 10, 2003
Aug. 29, 2002 How do you deal with competing patient demands for blood? REACTIVATED May 9, 2004; ADDENDA May 12, 13 & 17, 2004
Aug. 29, 2002 Reimbursement for the computer crossmatch procedure - revisited; ADDENDA Apr. 20, 22, 25; Nov. 17 & 21, 2005; Jan. 24 & Feb. 13, 2006
Aug. 27, 2002 Is routine donor screening for unexpected antibodies really necessary?
Aug. 16, 2002 Should one offer Rh immunoprophylaxis for a woman who delivers a baby determined to be Dvi positive? ADDENDA Aug. 17 & 28
Aug. 15, 2002 What is the current required lookback period for a donor testing confirmed positive for HIV-1 p24 antigen only? ADDENDA Aug. 16
Aug. 9, 2002 West Nile Virus and the US Blood Supply ADDENDA Sept. 15; UPDATED July 25, 2005
Aug. 8, 2002 Improved Methods for Quantitating Fetal-Maternal Hemorrhage ADDENDA Aug. 9; Jan. 12, 2005
Aug. 7, 2002 Should cellular blood products for exchange transfusion in neonates be routinely irradiated? ADDENDA Aug. 8
Aug. 6, 2002 What do you say to a non-blood banker pathologist who thinks the discipline of transfusion medicine is static?
Aug. 2, 2002 Should brain-dead persons whose organs qualify for harvesting and transplantation receive red cell transfusions to improve organ survival? ADDENDA Mar. 28, 2005
Aug. 1, 2002 What studies should be done to validate a new antiseptic before using it for arm preparation of blood donors? ADDENDA Dec. 28, 29 & 30, 2003
July 30, 2002 Reactions due to hypersensitivity to latex or thiuram in transfusion recipients
July 28, 2002 Unexplained Positive Direct Antiglobulin Test (DAT) results in both pre- and post-transfusion specimens associated with a febrile reaction to transfusion ADDENDA July 29
July 11, 2002 Selection of Red Cells for supporting Rh-positive recipients of Rh-negative marrow during and after engraftment ADDENDA July 13
June 28, 2002 Acceptable containers for temporary storage of blood in the operating room and ICU ADDENDA June 28 & July 2
June 24, 2002 When to use volume-reduced blood products for avoiding volume overload in patients at risk? ADDENDA June 24
June 21, 2002 Managing irradiated Red Cell inventory to prevent release of older units to patients at risk of hyperkalemia ADDENDA June 25
June 16, 2002 Could there be a link between blood transfusions and atherosclerosis? ADDENDA Jan. 8, 2006
June 14, 2002 Antibody titer studies in pregnant women at risk for bearing an infant with hemolytic disease of the newborn ADDENDA June 18 & 19; May 7, 10 & 16, 2008
June 13, 2002 Warm autoantibody-adsorption procedures with PEG ADDENDA Jan 9, 2005
June 12, 2002 Recommendations for storage of RHIG (Rh Immune Globulin) ADDENDA June 13 & 14
June 11, 2002 Should at-risk donors be interviewed and/or tested for T. cruzi infection to prevent transfusion-transmitted Chagas Disease? ADDENDA June 12 & 21; July 11; Aug. 1; Sept. 3; Nov 29 & 30, 2004; Feb. 19, 21 & 24, 2007
June 10, 2002 Prospective donors with rheumatoid arthritis, multiple sclerosis, ulcerative colitis, Crohn's disease, a history of Guillain-Barre syndrome ADDENDA June 11 REACTIVATED with ADDENDA Jan. 8, 2004
June 2, 2002 Pediatric Transfusion Guidelines - A Resource ADDENDA June 5
June 1, 2002 Crossmatching pediatric patients over age 4 months of age in anticipation of large volume operative and post-op blood loss ADDENDA June 3
May 31, 2002 Updated information regarding 'Blood Substitutes' ADDENDA June 3 & 10
May 30, 2002 Emergency reversal of Warfarin effect - FFP or Prothrombin Complex Concentrate? ADDENDA May 31; Jan. 5, 6, 8, 9, 10, 13, 15, 17 & 24, 2006
May 29, 2002 Validating igloo coolers that are used to 'store' blood in the operating room ADDENDA Feb. 7, 2007
May 28, 2002 Maintaining patency of intravenous lines between repeated therapeutic hemapheresis procedures ADDENDA May 29 & June 8
May 23, 2002 Transfusion support with RBC and plateletpheresis units for patients who are post auto/-allo BMT or solid organ transplantation ADDENDA May 24
May 22, 2002 Screening for sickle cell trait and informing blood donors of the test results
May 21, 2002 Questions about the use of blood component recipient sets ADDENDA May 28
May 16, 2002 Infusing drugs or IV solutions along with blood ADDENDA May 17, 20, 21, 22 & 23; Dec. 30, 2005; June 4, 2006
May 15, 2002 Documentation that blood has been transfused ADDENDA May 17
May 12, 2002 Transfusions that exceed four hours in duration ADDENDA May 13
May 12, 2002 Labeling specimens that may lead to compatibility testing RESPONSE May 23
May 10, 2002 The practice of transfusing out-of-type platelets ADDENDA May 11, 13 & 14; Sept. 2, 8, 20 & 29; Oct. 3, Nov. 1 & 2, 2005
May 9, 2002 Use of Type and Screen versus NO pre-operative blood orders for a patient who has a scheduled elective surgical procedure with a low likelihood of requiring blood transfusion  ADDENDA May 14, 15, 17 & 20
May 6, 2002 Neonatal transfusion practices  ADDENDA May 14; Dec. 15, 2008
May 3, 2002 RBC transfusions for a patient with ITP who is receiving IV anti-D therapy ADDENDA May 3, 6 & 7; Feb. 5 & 26, 2009
May 1, 2002 Transfusing donor RBC units obtained from individuals whose plasma contains unexpected antibodies ADDENDA May 2; Feb. 21, 2007; May 16 & June 25, 2008
April 30, 2002 How often should one repeat the antibody identification panel workup for a patient who is known to be alloimmunized? ADDENDA May 1, 2, 5, 8 & 9
April 28, 2002 Informing patients when pre-transfusion testing shows that their blood contains red cell antibodies ADDENDA April 29; June 8, 9, 12 & 16, 2006
April 23, 2002 Resolving Rh status of a newborn infant whose direct antiglobulin test is positive
April 21, 2002 Transfusion-Related Acute Lung Injury (TRALI) (REACTIVATED April 29, 2003) - a Serious and Under-recognized Complication of Transfusion. ADDENDA April 23, 24 & May 10, 2002; Mar. 19, 2008
April 16, 2002 Are single unit red cell transfusions still considered 'suboptimal care'? ADDENDA April 17
April 15, 2002 Calibrating Digital Timers ADDENDA April 16 & 22
April 13, 2002 Is it a safe practice to transfuse sickle trait donor RBC units to patients with sickle cell disease?
April 12, 2002 Does your hospital have a problem with STAT pre-transfusion testing orders for elective scheduled surgery? ADDENDA April 13 & 16, Dec. 30 & 31, 2005; Jan. 2, 5 & 8, 2006
April 9, 2002 Should transfusion of thalassemia patients be managed using phenotype-matched RBC donor units? ADDENDA April 15
April 8, 2002 What is an appropriate way for institutions to assure patient identification? ADDENDA April 11, 2002; Feb. 24 & 25, Mar. 2 & 5, 2006
April 8, 2002 Benchmark for blood use in open heart and valve replacement surgeries RESPONSES April 10 ADDENDA April 11
April 6, 2002 Concern over non-confirming reactive or false positive disease marker results
April 4, 2002 Deferral from blood donation of individuals who received human growth hormone
April 4, 2002 Using a microwave to thaw FFP ADDENDA Sept. 21, 2007; Mar. 16, 2009
April 3, 2002 A call for "benchmark" data for peer review of blood utilization ADDENDA April 4 & 5; Mar 23, 29 & April 6, 2005; Oct. 12, 2008
April 2, 2002 Reducing supernatant plasma of pooled platelets before administration to ABO-incompatible adult recipients ADDENDA April 3, 8 & 14
Mar. 29, 2002 Chagas Disease Found in Three Organ Transplant Recipients - Priorities for testing blood donors?
Mar. 21, 2002 Factor V inhibitors are a complication of bovine thrombin exposure
Mar. 20, 2002 Transporting patient-assigned blood products between hospitals
Mar. 18, 2002 Case report of a pediatric patient who received a transfusion of a pool of four platelet concentrates and experienced rigors and a rise in temperature to 40C ADDENDA Mar. 18
Mar. 12, 2002 Documenting disposal of blood removed by therapeutic phlebotomy ADDENDA Mar. 13
Mar. 5, 2002 Monitoring frequent platelet pheresis donors for developing thrombocytopenia ADDENDA Mar. 6
Mar. 5, 2002 Using pH paper to QC platelets ADDENDA Mar. 7 & 11
Feb. 28, 2002 Relabeling thawed FFP as thawed plasma ADDENDA Mar. 5, 2002; Dec. 16, 21 & 26, 2006
Feb. 26, 2002 Use of expired reagent panel cells ADDENDA Feb. 27 & 28
Feb. 20, 2002 Experience with OVERLY irradiated blood products? RESPONSE April 16
Feb. 20, 2002 Monitoring FFP for inadvertent thawing and refreezing ADDENDA Feb. 21 & 24
Feb. 12, 2002 Are concerns over adhesive leaching through a blood bag justified? ADDENDA Feb. 16 & 25, Mar. 5
Feb. 12, 2002 How important is it to avoid Rh mismatched platelets for Rh-negative female neonates? ADDENDA Feb. 16 & 17, Mar. 13 & 15
Feb. 10, 2002 Getting paid when you do the computer crossmatch procedure ADDENDA Mar 27, April 3 & 6
Feb. 6, 2002 Do tube stoppers or stopper byproducts cause crossmatch interferences?
Feb. 3, 2002 Guidance on the length of time a patient must be observed during the start of a transfusion ADDENDA Feb. 6
Jan. 30, 2002 Preventing pre-transfusion specimen labeling errors ADDENDA Jan 30 & 31, Feb. 3; June 20, 21 & Nov. 12, 2006
Jan. 27, 2002 How often should blood administration sets be changed while a patient is being transfused? ADDENDA May 16, 17 & 18, 2004
Jan. 22, 2002 Transfusion of patients who have paroxysmal nocturnal hemoglobinuria (PNH) ADDENDA Jan. 24
Jan. 19, 2002 Febrile transfusion reactions and/or rigors with almost EVERY platelet transfusion ADDENDA Jan. 20 & 23
Jan. 16, 2002 Recognition of patients who need special cellular products that are washed, irradiated, leukocyte-reduced and/or CMV negative ADDENDA Jan. 17, 21 & 30
Jan. 12, 2002 Hemolysis while 'processing' irradiated directed donor RBC units via a cell saver in the operating room ADDENDA Jan. 13
Jan. 6, 2002 X-ray examination of blood products as a security measure at the time of their delivery ADDENDA Jan. 7 & 10

Back to Top

The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.

 

 
Login Join